SCHEMBL16965985

SCHEMBL16965985

CNC(=O)Oc1sccc1Nc1nc(Nc2ccc3c(c2)NC(=O)C(NC(C)=O)CC3(C)C)ncc1Cl

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
INSR P06213 20/20 0.64
MET P08581 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL886358 0.89 INSR (0.69) INSRMET
SCHEMBL16966220 0.78 MET (0.60) INSRMET
SCHEMBL885980 0.78 INSR (1.00) INSRMET
SCHEMBL16965957 0.78 MET (0.46) INSRMET
SCHEMBL16965931 0.75 INSR (0.70) INSRMET
SCHEMBL16966242 0.74 INSR (0.64) INSRMET
SCHEMBL16966038 0.74 MET (0.61) INSRMET
SCHEMBL16965930 0.74 INSR (0.72) INSRMET
SCHEMBL886342 0.74 INSR (1.00) INSRMET
SCHEMBL16965961 0.73 MET (0.44) INSRMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2684874-B1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors CEPHALON INC (US) 2017-05-17 EP claimed
EP-2222647-B1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON INC (US) 2015-08-05 EP claimed